X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 51 filers reported holding X4 PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $460 | -90.8% | 529 | -89.4% | 0.00% | – |
| Q4 2022 | $5,000 | -44.4% | 4,969 | 0.0% | 0.00% | – |
| Q3 2022 | $9,000 | +80.0% | 4,969 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -95.7% | 4,969 | +452.7% | 0.00% | – |
| Q1 2022 | $117,000 | +11600.0% | 899 | +124.8% | 0.00% | – |
| Q4 2021 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 400 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |